A detailed history of Nomura Holdings Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 57,429 shares of SRPT stock, worth $6.53 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
57,429
Previous 57,429 -0.0%
Holding current value
$6.53 Million
Previous $7.17 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$124.33 - $156.75 $1.46 Million - $1.83 Million
-11,704 Reduced 16.93%
57,429 $7.17 Million
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $7.83 Million - $11.3 Million
69,133 New
69,133 $10.9 Million
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $963,746 - $1.28 Million
8,200 New
8,200 $1.13 Million
Q2 2022

Aug 15, 2022

BUY
$62.69 - $88.44 $276,525 - $390,108
4,411 Added 56.23%
12,256 $927,000
Q1 2022

May 18, 2022

BUY
$63.15 - $90.42 $495,411 - $709,344
7,845 New
7,845 $647,000
Q3 2021

Nov 15, 2021

SELL
$65.97 - $92.48 $1.47 Million - $2.06 Million
-22,248 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$69.38 - $86.75 $1.54 Million - $1.93 Million
22,248 New
22,248 $1.73 Million
Q1 2021

May 17, 2021

SELL
$72.25 - $168.95 $1.3 Million - $3.04 Million
-18,000 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $4.91 Million - $6.99 Million
-39,081 Reduced 68.47%
18,000 $3.07 Million
Q3 2020

Nov 12, 2020

BUY
$127.12 - $172.34 $7.26 Million - $9.84 Million
57,081 New
57,081 $8.03 Million
Q2 2020

Aug 14, 2020

SELL
$93.0 - $171.7 $1.02 Million - $1.89 Million
-11,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $906,180 - $1.45 Million
11,000 New
11,000 $1.08 Million
Q1 2020

May 14, 2020

SELL
$82.38 - $131.64 $65,904 - $105,311
-800 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$76.53 - $135.58 $895,401 - $1.59 Million
-11,700 Reduced 93.6%
800 $103,000
Q3 2019

Nov 14, 2019

SELL
$72.81 - $156.91 $14.5 Million - $31.1 Million
-198,500 Reduced 94.08%
12,500 $957,000
Q1 2019

May 14, 2019

BUY
$106.67 - $151.68 $21.7 Million - $30.9 Million
203,674 Added 2780.15%
211,000 $24.9 Million
Q4 2018

Feb 14, 2019

SELL
$97.32 - $148.76 $848,825 - $1.3 Million
-8,722 Reduced 54.35%
7,326 $799,000
Q3 2018

Nov 14, 2018

SELL
$115.31 - $161.51 $271,209 - $379,871
-2,352 Reduced 12.78%
16,048 $2.4 Million
Q2 2018

Aug 14, 2018

SELL
$71.74 - $153.69 $21.8 Million - $46.7 Million
-303,669 Reduced 94.29%
18,400 $1.89 Million
Q4 2017

Feb 14, 2018

SELL
$47.64 - $56.75 $4.86 Million - $5.78 Million
-101,914 Reduced 24.04%
322,069 $18 Million
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $15.1 Million - $20 Million
423,983
423,983 $19.2 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.96B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.